v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net loss $ (3,438,702) $ (1,259,620)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Amortization 574,713    
Debt amortization 336,270    
Change in right-of-use assets   17,994  
Loss on termination of lease     $ 199,724
Impairment of right-of-use assets   108,759  
Stock-based compensation 742,292    
Changes in assets and liabilities:      
Other Current Assets (450,615)    
Accounts receivable (11,334)    
Prepaid expenses (112,233) (88,550)  
Lease liabilities   (4,925)  
Deposits   49,129  
Accounts payable 191,563 (109,320)  
Due to related parties (2,260)    
Deferred tax liability (317,698)    
Accrued expenses 572,754 51,832  
Other current liabilities 128,499    
Other liabilities   416,066  
Net cash used in operating activities (1,786,751) (818,635)  
Cash flows from financing activities:      
Proceeds from warrants exercise 454,628    
Proceeds from promissory notes 999,000    
Repayments of note payable   700,000  
Net cash provided by financing activities 1,453,628 700,000  
Effect of exchange rate changes on cash (181,119)    
Net decrease in cash, cash equivalents (514,242) (118,635)  
Cash, cash equivalents beginning balance 899,784 184,992 184,992
Cash, cash equivalents ending balance 385,542 66,357 $ 899,784
Non-cash investing and financing activities:      
Accrued dividends on Series B preferred stock 81,262 $ 81,262  
Warrants granted with promissory 318,428    
Promissory notes settled for warrants exercise 653,303    
Shareholder receivable $ 163,500